Drug Type Small molecule drug |
Synonyms Ki23057 |
Target |
Mechanism FGFR2 antagonists(Fibroblast growth factor receptor 2 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC30H35N3O4 |
InChIKeyVQCDZFWRGXFUMS-UHFFFAOYSA-N |
CAS Registry516523-31-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Stomach Cancer | Preclinical | JP | 01 Nov 2006 |